Abstract |
We examined the effect of a novel tachykinin NK-2-receptor antagonist, N alpha-(tert-Butylcarbamoyl)-L-glutaminyl-L-tryptophyl-alpha-aza- phenylalanine 2-benzyloxyethylamide (TAC-363), on hyperventilation- and citric acid-induced bronchoconstriction and neurokinin A (NKA)-, capsaicin- and antigen-induced airway hyperresponsiveness in guinea pigs. The i.v. administration of TAC-363 at doses of 0.01-1 mg/kg inhibited hyperventilation- and citric acid-induced bronchoconstriction in a dose-dependent manner, while FK-888, a tachykinin NK-1-receptor antagonist, did not inhibit hyperventilation-induced bronchoconstriction. NKA-induced airway hyperresponsiveness to acetylcholine was attenuated by i.v. injection of TAC-363, but not by the thromboxane A2 synthetase inhibitor ozagrel and the mast cell stabilizer DSCG. Furthermore, TAC-363 prevented the occurrence of capsaicin- and antigen-induced airway hyperresponsiveness to acetylcholine, while FK-888 did not prevent occurrence of capsaicin-induced airway hyperresponsiveness. In summary, TAC-363 inhibits bronchoconstriction and airway hyperresponsiveness induced by various stimuli. These results suggest that NKA mediates bronchoconstriction and airway hyperresponsiveness. Thus, TAC-363 is expected to be useful in the treatment of airway diseases such as asthma.
|
Authors | Y Higashide, Y Yatabe, Y Arai, M Shibata, T Yamaura |
Journal | Nihon yakurigaku zasshi. Folia pharmacologica Japonica
(Nihon Yakurigaku Zasshi)
Vol. 109
Issue 1
Pg. 19-29
(Jan 1997)
ISSN: 0015-5691 [Print] Japan |
PMID | 9067996
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Oligopeptides
- Receptors, Tachykinin
- TAC 363
- Tachykinins
- Citric Acid
- Neurokinin A
- Capsaicin
|
Topics |
- Animals
- Bronchoconstriction
(drug effects)
- Capsaicin
(pharmacology)
- Citric Acid
(pharmacology)
- Guinea Pigs
- Hyperventilation
(physiopathology)
- Male
- Neurokinin A
(pharmacology)
- Oligopeptides
(pharmacology)
- Receptors, Tachykinin
(antagonists & inhibitors)
- Respiratory Hypersensitivity
(prevention & control)
- Tachykinins
(antagonists & inhibitors)
|